{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T03:56:50Z","timestamp":1768103810195,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204809\/Z\/16\/Z"],"award-info":[{"award-number":["204809\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pt.2020.10.003","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T18:06:03Z","timestamp":1603130763000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Repurposing Antimalarials to Tackle the COVID-19 Pandemic"],"prefix":"10.1016","volume":"37","author":[{"given":"Sanjeev","family":"Krishna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengchao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry M.","family":"Staines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Platteeuw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeeba","family":"Kamarulzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amadou","family":"Sall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2020.10.003_bb0005","article-title":"Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial","author":"Horby","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.pt.2020.10.003_bb0010","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/cid\/ciz580","article-title":"Pyronaridine-artesunate efficacy and safety in uncomplicated Plasmodium falciparum malaria in areas of artemisinin-resistant falciparum in Viet Nam (2017\u20132018)","volume":"70","author":"Quang Bui","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2020.10.003_bb0015","article-title":"Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza","author":"Bae","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.pt.2020.10.003_bb0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijid.2020.08.032","article-title":"Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate","volume":"99","author":"Gendrot","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.pt.2020.10.003_bb0025","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.pt.2020.10.003_bb0030","first-page":"767","article-title":"SARS-CoV-2, which induces COVID-19, causes Kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines","volume":"34","author":"Ronconi","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.pt.2020.10.003_bb0035","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(20)30922-3","article-title":"Ethnicity and COVID-19: an urgent public health research priority","volume":"395","author":"Pareek","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.10.003_bb0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2020.10.003_bb0045","article-title":"Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials","author":"Baker","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pt.2020.10.003_bb0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1159\/000489982","article-title":"Artesunate attenuates pro-inflammatory cytokine release from macrophages by inhibiting TLR4-mediated autophagic activation via the TRAF6-Beclin1-PI3KC3 pathway","volume":"47","author":"Kuang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.pt.2020.10.003_bb0055","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/SLA.0000000000001664","article-title":"Artesunate protects against the organ injury and dysfunction induced by severe hemorrhage and resuscitation","volume":"265","author":"Sordi","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.pt.2020.10.003_bb0060","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s10753-017-0524-6","article-title":"Artesunate protects LPS-induced acute lung injury by inhibiting TLR4 expression and inducing Nrf2 activation","volume":"40","author":"Zhao","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.pt.2020.10.003_bb0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10753-017-0669-3","article-title":"Artesunate inhibits renal ischemia reperfusion-stimulated lung inflammation in rats by activating HO-1 pathway","volume":"41","author":"Liu","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.pt.2020.10.003_bb0070","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.3892\/mmr.2017.7362","article-title":"Effects of artesunate prevent nephritis via the Toll-like receptor 4\/nuclear factor kappaB signaling pathway in rats","volume":"16","author":"Wan","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.pt.2020.10.003_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbi.2018.07.011","article-title":"Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4\/NF-kappaB\/NLRP3 inflammasome pathway","volume":"293","author":"Sun","year":"2018","journal-title":"Chem. Biol. Interact."}],"updated-by":[{"DOI":"10.1016\/j.pt.2020.12.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220302889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492220302889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:35:58Z","timestamp":1761464158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492220302889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1471492220302889"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2020.10.003","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Antimalarials to Tackle the COVID-19 Pandemic","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2020.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}